S, A., A, A., S, B., M, C., B, K., AK, C., . . . V, M. (2023). Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: A prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial. The Lancet. Haematology, 10(6), e445. https://doi.org/10.1016/S2352-3026(23)00062-5
Chicago Style (17th ed.) CitationS, Alexander, et al. "Effect of Rituximab on Immune Status in Children with Mature B-cell Non-Hodgkin Lymphoma: A Prespecified Secondary Analysis of the Inter-B-NHL Ritux 2010 Trial." The Lancet. Haematology 10, no. 6 (2023): e445. https://doi.org/10.1016/S2352-3026(23)00062-5.
MLA (9th ed.) CitationS, Alexander, et al. "Effect of Rituximab on Immune Status in Children with Mature B-cell Non-Hodgkin Lymphoma: A Prespecified Secondary Analysis of the Inter-B-NHL Ritux 2010 Trial." The Lancet. Haematology, vol. 10, no. 6, 2023, p. e445, https://doi.org/10.1016/S2352-3026(23)00062-5.